In the media
News
Partner news
Syndesi Therapeutics announces successful completion of first-in-human Phase I study of novel SV2A modulator, SDI-118, in development for the treatment of cognitive impairment.
Read full storyIn the media
Medopad And Janssen Develop Automated Digital Test To Detect Alzheimer’s Earlier
Read full storyPress release
Janssen Korea Ltd. and Johnson & Johnson Innovation Announced Awardees of the Seoul Innovation QuickFire Challenge in Smart Healthcare in Collaboration with the Seoul Metropolitan Government and Korea Health Industry Development Institute
Read full storyPartner news